HRTX logo

Heron Therapeutics, Inc. (HRTX)

Profile

Full Name

Heron Therapeutics, Inc.

Ticker

NASDAQ: HRTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 26, 1987

Indexes

Not included

Website

https://www.herontx.com

Employees

122

Key Details

Price

$1.24(-1.59%)

Market cap

$190.08M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$144.28M(+13.57% YoY)

Annual EPS

-$0.09(+88.75% YoY)

PE ratio

-

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.24
    HRTX price is $1.24

    30-Day Relative Volume

    0.45
    HRTX 30-day relative volume is 0.45

    Price Performance

    Price Most recent change

    -1.59%
    HRTX price was down -1.59% on Sep 15, 2025

    Price YTD change

    -18.95%
    HRTX price is down -18.95% since January 1st

    Price 1-year change

    -33.69%
    HRTX price is down -33.69% year-on-year

    Price 3-year change

    -74.54%
    HRTX price is down -74.54% over the past 3 years

    Price Range

    Price All-time high

    $1290.00
    HRTX price is currently -99.90% below its historical high of $1290.00

    Price 3-year low

    $0.50
    HRTX price is currently +148.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $190.08M
    HRTX market capitalization is $190.08 million

    Market cap 3-year change

    -67.13%
    HRTX market capitalization is down -67.13% over the past 3 years

    Market cap All-time high

    $3.18B
    HRTX market capitalization is currently -94.02% below its historical high of $3.18 billion

    Market cap sector rank

    49.66%
    HRTX market capitalization is higher than 49.66% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.07%
    HRTX shares outstanding is up +1.07% year-on-year

    Shares Outstanding 3-Year Change

    +29.08%
    HRTX shares outstanding is up +29.08% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.91
    HRTX beta is 0.91

    200-day SMA

    $1.84
    HRTX price is currently -32.71% below its 200-day simple moving average

    50-day SMA

    $1.62
    HRTX price is currently -23.67% below its 50-day simple moving average

    RSI

    30.48
    HRTX 14-day relative strength index is 30.48

    Volume

    0.45
    HRTX 30-day relative volume is 0.45

    ATR

    $0.07
    HRTX average true range is $0.07

    10-day Historical Volatility

    17.62%
    HRTX 10-day historical volatility is 17.62%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $144.28M
    HRTX annual revenue is $144.28 million

    Revenue Analysts estimate

    $156.48M
    HRTX annual revenue is currently -7.79% lower than the consensus analysts' forecast

    Revenue 1-year change

    +13.57%
    HRTX annual revenue is up +13.57% year-on-year

    Revenue Sector rank

    71.46%
    HRTX annual revenue is higher than 71.46% of companies in Healthcare sector

    EPS

    EPS

    -$0.09
    HRTX annual earnings per share is -$0.09

    EPS Analysts estimate

    -$0.03
    HRTX annual earnings per share is currently +237.08% higher than the consensus analysts' forecast

    EPS 1-year change

    +88.75%
    HRTX annual earnings per share is up +88.75% year-on-year

    EPS Sector rank

    73.53%
    HRTX annual earnings per share is higher than 73.53% of companies in Healthcare sector

    Profit

    Gross profit

    $105.64M
    HRTX annual gross profit is $105.64 million

    Gross margin

    73.21%
    HRTX annual gross profit margin is 73.21%

    Operating profit

    -$11.53M
    HRTX annual operating income is -$11.53 million

    Operating margin

    -7.99%
    HRTX annual operating profit margin is -7.99%

    Net income

    -$13.58M
    HRTX annual net profit is -$13.58 million

    Net margin

    -9.41%
    HRTX annual net profit margin is -9.41%

    Expenses

    Total expenses

    $155.81M
    HRTX annual total expenses is $155.81 million

    Operating expenses

    $117.17M
    HRTX annual total operating expenses is $117.17 million

    Cost of goods sold

    $38.65M
    HRTX annual cost of goods sold is $38.65 million

    Selling, general & administrative expenses

    $100.48M
    HRTX annual SGA is $100.48 million

    Depreciation and amortization

    $2.49M
    HRTX annual depreciation & amortization is $2.49 million

    Interest expense

    $0.00
    HRTX annual interest expense is $0.00

    Income tax

    $0.00
    HRTX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$7.55M
    HRTX annual earnings before interest & taxes is -$7.55 million

    EBITDA

    -$5.06M
    HRTX annual EBITDA is -$5.06 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $233.15M
    HRTX annual total assets is $233.15 million

    Non current assets

    $24.13M
    HRTX annual long term assets is $24.13 million

    Current assets

    $209.01M
    HRTX annual total current assets is $209.01 million

    Cash and cash equivalents

    $25.80M
    HRTX annual cash & cash equivalents is $25.80 million

    Accounts receivable

    $78.88M
    HRTX annual accounts receivable is $78.88 million

    Inventory

    $53.16M
    HRTX annual inventory is $53.16 million

    Liabilities

    Total liabilities

    $266.80M
    HRTX annual total liabilities is $266.80 million

    Long term liabilities

    $175.34M
    HRTX annual total long term liabilities is $175.34 million

    Current liabilities

    $91.46M
    HRTX annual total current liabilities is $91.46 million

    Accounts payable

    $11.71M
    HRTX annual accounts payable is $11.71 million

    Debt

    Total debt

    $177.76M
    HRTX annual total debt is $177.76 million

    Total debt 1-year change

    -1.04%
    HRTX annual total debt is down -1.04% year-on-year

    Long term debt

    $174.73M
    HRTX annual long term debt is $174.73 million

    Short term debt

    $3.04M
    HRTX annual short term debt is $3.04 million

    Equity & Capital

    Shareholders equity

    -$33.65M
    HRTX annual stockholders equity is -$33.65 million

    Book value

    -$33.65M
    HRTX annual book value is -$33.65 million

    Retained earnings

    -$1.92B
    HRTX annual retained earnings is -$1.92 billion

    Working capital

    $117.56M
    HRTX annual working capital is $117.56 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$22.53M
    HRTX annual cash flow from operations is -$22.53 million

    Cash from operations 1-year change

    +61.68%
    HRTX annual cash flow from operations is up +61.68% year-on-year

    Cash from investing

    $18.71M
    HRTX annual cash flow from investing activities is $18.71 million

    Cash from investing 1-year change

    +4%
    HRTX annual cash flow from investing activities is up +4% year-on-year

    Cash from financing

    $940.00K
    HRTX annual cash flow from financing activities is $940.00 thousand

    Cash from financing 1-year change

    -98.26%
    HRTX annual cash flow from financing activities is down -98.26% year-on-year

    CAPEX

    CAPEX

    $1.71M
    HRTX annual capital expenditures is $1.71 million

    CAPEX 1-year change

    +10.42%
    HRTX annual capital expenditures is up +10.42% year-on-year

    Free Cash Flow

    Free cash flow

    -$24.23M
    HRTX annual free cash flow is -$24.23 million

    Free cash flow 1-year change

    +59.83%
    HRTX annual free cash flow is up +59.83% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    73.21%
    HRTX annual gross profit margin is 73.21%

    Operating margin

    -7.99%
    HRTX annual operating profit margin is -7.99%

    Net margin

    -9.41%
    HRTX annual net profit margin is -9.41%

    ROA & ROE

    ROA

    -5.96%
    HRTX annual return on assets is -5.96%

    ROE

    40.36%
    HRTX annual return on equity is 40.36%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    HRTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    HRTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -6.97
    HRTX price to book ratio is -6.97

    PB ratio Sector rank

    5.47%
    HRTX price to book ratio is higher than 5.47% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.27
    HRTX price to sales ratio is 1.27

    PS ratio Sector rank

    24.63%
    HRTX price to sales ratio is higher than 24.63% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $326.19M
    HRTX enterprise value is $326.19 million

    Enterprise value Sector rank

    61.45%
    HRTX enterprise value is higher than 61.45% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    43.28
    HRTX EV/EBITDA is 43.28

    EV/EBITDA Sector rank

    95.88%
    HRTX EV/EBITDA is higher than 95.88% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.29
    HRTX annual current ratio is 2.29

    Quick ratio

    1.70
    HRTX annual quick ratio is 1.70

    Leverage

    Debt to equity

    -5.19
    HRTX annual debt to equity ratio is -5.19

    Interest coverage ratio

    -
    HRTX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    HRTX piotroski f-score is 3

    Altman Z-Score

    -9.98
    HRTX altman z-score is -9.98

    Analyst ratings

    Recent major analysts updates

    Aug 8, 25 Needham
    Buy
    Jun 9, 25 HC Wainwright & Co.
    Buy
    Apr 11, 25 Needham
    Buy
    Feb 28, 25 Needham
    Buy
    Dec 4, 24 Needham
    Buy
    Nov 13, 24 Needham
    Buy
    Sep 25, 24 Needham
    Buy
    Aug 7, 24 Needham
    Buy
    Jun 13, 24 Rodman & Renshaw
    Buy
    May 16, 24 Needham
    Buy

    Institutional Ownership

    Screeners with HRTX included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Heron Therapeutics, Inc.?
    • Does Heron Therapeutics, Inc. pay dividends?
    • What sector is Heron Therapeutics, Inc. in?
    • What industry is Heron Therapeutics, Inc. in?
    • What country is Heron Therapeutics, Inc. based in?
    • When did Heron Therapeutics, Inc. go public?
    • Is Heron Therapeutics, Inc. in the S&P 500?
    • Is Heron Therapeutics, Inc. in the NASDAQ 100?
    • Is Heron Therapeutics, Inc. in the Dow Jones?
    • When was Heron Therapeutics, Inc.'s last earnings report?
    • When does Heron Therapeutics, Inc. report earnings?

    What is the ticker symbol for Heron Therapeutics, Inc.?

    The ticker symbol for Heron Therapeutics, Inc. is NASDAQ:HRTX

    Does Heron Therapeutics, Inc. pay dividends?

    No, Heron Therapeutics, Inc. does not pay dividends

    What sector is Heron Therapeutics, Inc. in?

    Heron Therapeutics, Inc. is in the Healthcare sector

    What industry is Heron Therapeutics, Inc. in?

    Heron Therapeutics, Inc. is in the Biotechnology industry

    What country is Heron Therapeutics, Inc. based in?

    Heron Therapeutics, Inc. is headquartered in United States

    When did Heron Therapeutics, Inc. go public?

    Heron Therapeutics, Inc.'s initial public offering (IPO) was on August 26, 1987

    Is Heron Therapeutics, Inc. in the S&P 500?

    No, Heron Therapeutics, Inc. is not included in the S&P 500 index

    Is Heron Therapeutics, Inc. in the NASDAQ 100?

    No, Heron Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Heron Therapeutics, Inc. in the Dow Jones?

    No, Heron Therapeutics, Inc. is not included in the Dow Jones index

    When was Heron Therapeutics, Inc.'s last earnings report?

    Heron Therapeutics, Inc.'s most recent earnings report was on August 8, 2025

    When does Heron Therapeutics, Inc. report earnings?

    The next expected earnings date for Heron Therapeutics, Inc. is November 10, 2025
    On this page